End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.57 CNY | -1.57% | -12.71% | -33.03% |
Mar. 15 | Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback | MT |
2023 | Kanghui Pharma Sanctioned Over Failure to Disclose M&A Deal | MT |
Sales 2021 | 443M 61.1M | Sales 2022 | 492M 67.83M | Capitalization | 1.77B 245M |
---|---|---|---|---|---|
Net income 2021 | 36M 4.97M | Net income 2022 | -63M -8.69M | EV / Sales 2021 | 5.3 x |
Net Debt 2021 | 172M 23.73M | Net Debt 2022 | 313M 43.21M | EV / Sales 2022 | 4.24 x |
P/E ratio 2021 |
58.8
x | P/E ratio 2022 |
-28.2
x | Employees | 828 |
Yield 2021 |
0.34% | Yield 2022 |
-
| Free-Float | 39.72% |
1 day | -1.57% | ||
1 week | -12.71% | ||
Current month | -17.90% | ||
1 month | -18.11% | ||
3 months | -23.12% | ||
6 months | -31.57% | ||
Current year | -33.03% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Ling Wang
CEO | Chief Executive Officer | 64 | 98-12-31 |
Bin Ze Zou
DFI | Director of Finance/CFO | 37 | 18-12-10 |
Jin Yang
BRD | Director/Board Member | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Ping Hou
BRD | Director/Board Member | 63 | 09-12-10 |
Wai Tao Ye
BRD | Director/Board Member | 51 | 12-10-31 |
Yan Ling Wang
CEO | Chief Executive Officer | 64 | 98-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 12.57 | -1.57% | 1,319,500 |
24-04-19 | 12.77 | -2.30% | 1,782,000 |
24-04-18 | 13.07 | -2.39% | 2,108,102 |
24-04-17 | 13.39 | +3.32% | 2,406,300 |
24-04-16 | 12.96 | -10.00% | 1,905,400 |
End-of-day quote Shanghai S.E., April 21, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-33.03% | 173M | |
+17.88% | 44.31B | |
+19.87% | 22.17B | |
+15.11% | 14.62B | |
+8.06% | 13.12B | |
+39.21% | 11.58B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.50% | 5.03B |
- Stock Market
- Equities
- 603139 Stock